ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION)

This adverse event was reported 19 times

ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION) is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEXRAZOXANE FOR INJECTION 2 0.0021
1 TERBINAFINE TABLETS 250 MG 1 0.0008
2 PEGFILGRASTIM-CBQV 1 0.0007
3 ANIDULAFUNGIN 1 0.0006
4 BLINATUMOMAB 2 0.0002
5 MITOXANTRONE HYDROCHLORIDE 1 0.0002
6 TERBINAFINE HYDROCHLORIDE 1 0.0001
7 THIOTEPA 1 0.0001
8 IFOSFAMIDE FOR INJECTION 2 0.0001
9 STANDARDIZED SENNA CONCENTRATE 1 0.0001
See all drugs enriched for association with ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION)